SCHEMBL5552968

SCHEMBL5552968

CCCCCCCCCCC=N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.52
THRB P10828 1/20 0.50
FAAH O00519 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
DNM1 Q05193 3/20 0.45
EP300 Q09472 1/20 0.41
GMNN O75496 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
APEX1 P27695 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3747325 1.00
SCHEMBL31094592 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL1546235 1.00
SCHEMBL17848839 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL3742815 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL23869543 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL3744463 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL3742821 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL3684198 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1
SCHEMBL27871715 1.00 TSHR (0.52) TSHRTHRBFAAHTRPV1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040754-A1 METHOD FOR SYNTHESIZING CIS-2-METHYL-7-OCTADECENE AND CIS-7,8-EPOXY-2-METHYLOCTADECANE 南京蕃茂生物科技有限公司 2024-02-29 WO disclosed
WO-2024027931-A1 ODOR AND COLORANT STABILIZED COMPOSITIONS SYMRISE AG (DE) 2024-02-08 WO disclosed
US-20240018111-A1 ALPHA, BETA UNSATURATED METHACRYLIC ESTERS WITH ANTI-INFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2024-01-18 US disclosed
US-11874563-B2 Photoaligning polymer materials Rolic Technologies AG (CH) 2024-01-16 US disclosed
CN-113412251-B Methods and compositions for preparing photoaligned polymeric materials 罗利克技术有限公司 2023-11-28 CN disclosed
CN-110511924-B Isolation of micrornas from biological fluids 西格马-奥尔德里奇有限责任公司 2023-11-03 CN disclosed
CN-116891506-A Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device 三星电子株式会社 2023-10-17 CN disclosed
CN-116640169-A Organometallic compound, light-emitting device, and electronic device 三星显示有限公司 2023-08-25 CN disclosed
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-08-22 US disclosed
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES SITRYX THERAPEUTICS LIMITED (GB) 2023-07-13 US disclosed
WO-2006053615-A1 FRAGRANCE COMBINATION COMPRISING 3,7-DIMETHYLOCT-6-ENE NITRILE (CITRONELLYL NITRILE) AS GERANONITRILE SUBSTITUTE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-05-26 WO disclosed
CN-1377406-A Protease conjugates having sterically protected clip sites PROCTER & GAMBLE (US) 2002-10-30 CN disclosed
CN-1372593-A Protease conjugates having sterically protected epitope regions PROCTER & GAMBLE (US) 2002-10-02 CN disclosed
CN-1369008-A Intramolecularly cross-linked subtilisins with reduced immunogenicity PROCTER & GAMBLE (US) 2002-09-11 CN disclosed
US-6410593-B1 MIXTURE OF ANIONIC SURFACTANT, AMPHOTERIC SURFACTANT AND FUNGICIDES CECA S.A. (FR) 2002-06-25 US disclosed
EP-1112079-B1 MYRTLE EXTRACT, PREPARATION METHOD AND USE FABRE PIERRE DERMO COSMETIQUE (FR) 2002-04-17 EP disclosed
EP-1112079-A1 MYRTLE EXTRACT, PREPARATION METHOD AND USE Pierre Fabre Dermo-Cosmetique (FR) 2001-07-04 EP disclosed
WO-2000016791-A1 MYRTLE EXTRACT, PREPARATION METHOD AND USE PIERRE FABRE DERMO-COSMETIQUE (FR) 2000-03-30 WO disclosed
EP-0566339-B1 Cosmetic composition UNILEVER PLC (GB) 1997-09-10 EP disclosed
US-5236710-A Cleaning compound ELIZABETH ARDEN COMPANY (US) 1993-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219907-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES CPA2, RO60, C5AR1 TSHR 3550/4885THRB 4456/4885FAAH 1426/4885
US-20240018111-A1 ALPHA, BETA UNSATURATED METHACRYLIC ESTERS WITH ANTI-INFLAMMATORY PROPERTIES PTGS1, PTGER1, PTGES2 TSHR 3299/4885THRB 1165/4885FAAH 189/4885
US-11731990-B2 Carbazole-based Bodipys for organic electroluminescent devices CYP1B1, ECI1, FIS1 TSHR 4501/4885THRB 3938/4885FAAH 2909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.